Symbiotec Pharmalab IPO enters its final bidding day with 5.31 times overall subscription and a Rs 285 GMP. The Rs 1,757 crore issue is priced at Rs 938–988 per share, with listing expected on September 1. Proceeds will partly repay debt, while investors weigh strong demand against premium valuation and risks.
Symbiotec Pharmalab IPO enters its final bidding day with 5.31 times overall subscription and a Rs 285 GMP. The Rs 1,757 crore issue is priced at Rs 938–988 per share, with listing expected on September 1. Proceeds will partly repay debt, while investors weigh strong demand against premium valuation and risks.
<iframe src="https://hindustansphere.com/embed/cluster/845e32b52a5c73337c4cc48a3845e92aee6642d1" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?"></iframe>
